New pill could tame ulcerative colitis without needles
Disease control
Recruiting now
This study tests an oral biologic called MB-001 in 100 adults with moderate-to-severe ulcerative colitis. Participants take either MB-001 or a placebo daily for 12 weeks, then may continue in an open-label phase. Researchers will check for side effects and measure improvements in…
Phase: PHASE1, PHASE2 • Sponsor: Mage Biologics • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC